Paper41003778
Risks and benefits of delaying hernia repair in patients with obesity: a retrospective case series of emergent hernia cases.
Li HW and 5 others. Surg Endosc, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Risks and benefits of delaying hernia repair in patients with obesity: a retrospective case series of emergent hernia cases. Papers, record 41003778. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003778
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risks and benefits of delaying hernia repair in patients with obesity: a retrospective case series of emergent hernia cases.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Herniorrhaphy | Major topic |
| Hernia, Ventral | Major topic |
| Obesity, Morbid | Major topic |
| Time-to-Treatment | Major topic |
| Obesity | Major topic |
| Humans | |
| Retrospective Studies | |
| Middle Aged | |
| Female | |
| Male | |
| Aged | |
| Postoperative Complications | |
| Risk Assessment | |
| Risk Factors | |
| Recurrence | |
| Surgical Mesh |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37840095 | Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. | Nat Med | 2023 | https://conductscience.org/library/papers/37840095 | PubMed |
| 2 | 30392164 | Predictors of mortality after elective ventral hernia repair: an analysis of national inpatient sample. | Hernia | 2019 | https://conductscience.org/library/papers/30392164 | PubMed |
| 3 | 38536183 | Year-Over-Year Ventral Hernia Recurrence Rates and Risk Factors. | JAMA Surg | 2024 | https://conductscience.org/library/papers/38536183 | PubMed |
| 4 | 37409072 | Association of body mass index with morbidity following elective ventral hernia repair. | Surg Open Sci | 2023 | https://conductscience.org/library/papers/37409072 | PubMed |
| 5 | 33743971 | Ventral Hernia Management in Obese Patients. | Surg Clin North Am | 2021 | https://conductscience.org/library/papers/33743971 | PubMed |
| 6 | 36689981 | Semaglutide (Wegovy) for the Treatment of Obesity. | Am Fam Physician | 2023 | https://conductscience.org/library/papers/36689981 | PubMed |
| 7 | 27750295 | Long-term Recurrence and Complications Associated With Elective Incisional Hernia Repair. | JAMA | 2016 | https://conductscience.org/library/papers/27750295 | PubMed |
| 8 | 35578162 | Defining a Body Mass Index Threshold for Preventing Recurrence in Ventral Hernia Repairs. | Am Surg | 2022 | https://conductscience.org/library/papers/35578162 | PubMed |
| 9 | 23494458 | Ventral hernias in morbidly obese patients: a suggested algorithm for operative repair. | Obes Surg | 2013 | https://conductscience.org/library/papers/23494458 | PubMed |
| 10 | 9717418 | Gastric bypass operation for obesity. | World J Surg | 1998 | https://conductscience.org/library/papers/9717418 | PubMed |
| 11 | 19495920 | Classification of primary and incisional abdominal wall hernias. | Hernia | 2009 | https://conductscience.org/library/papers/19495920 | PubMed |
| 12 | 37488442 | Management of abdominal wall hernias in patients with severe obesity. | Surg Endosc | 2023 | https://conductscience.org/library/papers/37488442 | PubMed |
| 13 | 30980102 | Risk Factors for Incarceration in Patients with Primary Abdominal Wall and Incisional Hernias: A Prospective Study in 4472 Patients. | World J Surg | 2019 | https://conductscience.org/library/papers/30980102 | PubMed |
| 14 | 35230401 | Reoperation for Recurrence Up to 10 Years After Hernia Repair. | JAMA | 2022 | https://conductscience.org/library/papers/35230401 | PubMed |
| 15 | 27440197 | What is the BMI threshold for open ventral hernia repair? | Surg Endosc | 2017 | https://conductscience.org/library/papers/27440197 | PubMed |
| 16 | 36971526 | Preoperative Optimization Before Ventral Hernia Repair: A Systematic Review and Meta-analysis. | Surg Laparosc Endosc Percutan Tech | 2023 | https://conductscience.org/library/papers/36971526 | PubMed |
| 17 | 26440803 | The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. | PLoS Med | 2015 | https://conductscience.org/library/papers/26440803 | PubMed |
| 18 | 33567185 | Once-Weekly Semaglutide in Adults with Overweight or Obesity. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33567185 | PubMed |
| 19 | 25564946 | Trends in emergent hernia repair in the United States. | JAMA Surg | 2015 | https://conductscience.org/library/papers/25564946 | PubMed |
| 20 | 28804507 | 2017 update of the WSES guidelines for emergency repair of complicated abdominal wall hernias. | World J Emerg Surg | 2017 | https://conductscience.org/library/papers/28804507 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41003778
GET https://conductscience.org/api/papers/v1/41003778/references?page=2